IN3 East 2010

RepRegen™, Ltd.

First Time Presenter

London, United Kingdom

Repregen™ is a London-based medical device company that uses patented repair and regeneration technology platforms designed to mend and regrow hard-tissue such as bone and soft-tissue such as cartilage.

MenRx Surgical LLC

Jacksonville, FL

MenRx Surgical markets the Pro-Vas Occlusion Device which provides men seeking a permanent form of contraception with a less-invasive alternative to vasectomy.

CeQur, Ltd.

First Time Presenter

Hellerup, Denmark

CeQur's lead product candidate is a small, wearable insulin delivery device that delivers both basal and bolus doses subcutaneously. Its simple and discrete design enables patients to more easily comply with insulin regimens and experience the benefits of intensive insulin therapy.

GeneEx, Inc.

Hialeah, FL

GeneEx is developing rapid, point-of-care saliva tests for infectious diseases capable of detecting virulence markers produced only during active infections.

Kerecis Limited

Reykjavik, Iceland

Novel tissue regeneration product for chronic wounds and hernia repair. Its patent pending fish skin derived material improves upon current human and porcine technologies through improved economics and clinical performance, reduced disease transfer risk and absence of cultural constraints on usage.

Paramed Srl

Genova, Italy

Paramed Medical Systems Inc. has developed an open MRI scanner called MRopen. MRopen 0.5 T uses open-sky superconductive U-shaped magnet with no barriers in between the patient and the environment. The magnet gap of 60 cm enables an easy access and positioning, along with a greater patient acceptance.

CardioInsight Technologies Inc.

First Time Presenter

Cleveland, OH

CardioInsight is developing the first non-invasive, real-time, beat-to-beat simultaneous mapping and localization solution for the treatment of cardiac arrhythmias and heart failure.

Aerolase

Tarrytown, NY

Aerolase is a commercial stage company that has developed, manufactures and markets the LightPod® platform technology of unique, proprietary (protected by 5 U.S. patents), portable high power lasers for use in aesthetic and dermatological applications including wound healing and onychomycosis.

Aura Medsystems, Inc.

New York, NY

Aura’s Light activated Soft Tissue Repair system obviates the need for implanting sutures, staples, and glues thus allowing the body to repair and heal itself.

ThermopeutiX, Inc.

San Diego, CA

THERMOPEUTIX, INC has developed a proprietary catheter system/ treatment for ischemic brain injury. Primary markets are cardiac arrest, acute stroke and trauma.

Prochon Biotech, Ltd.

Woburn, MA

Novel Fibroblast Growth Factor variants (FGF2v, FGF4v, FGF9v) for therapeutic and reagent/cell expansion applications with a commercial focus on articular cartilage repair and regeneration.

Aciont, Inc.

First Time Presenter

Salt Lake City, UT

Non-invasive, controlled and sustained release back of the eye therapeutics for sight threatening diseases such as severe uveitis, diabetic macular edema and age-related macular degeneration.

Valam Corp.

First Time Presenter

New York, NY

Proving the clinical and quality-of-life benefits of cost-effective, laser-based antimicrobial treatments for Chronic Rhinosinusitis (CRS).

Elemé Medical

First Time Presenter

Merrimack, NH

Elemé Medical is a commercial stage medical aesthetics company providing market-leading proprietary body shaping technologies. The Company has launched two devices: SmoothShapes® and SmoothShapes® XV.

OvaTech, Inc.

First Time Presenter

Auburndale, MA

Emerging medical technology company that is focused on products to enhance women's health in the contraceptive space.

NuVue Therapeutics, Inc.

Fairfax, VA

Biotechnology-driven, medical device company that has developed, and brings to market, a totally new and innovative image-guided, site-specific, drug and cryothermally mediated, regimen of cancer therapy for soft tissue tumors.

Chesson Labs

First Time Presenter

Durham, NC

All of Chesson Labs products cleared for market and in development are based on this patented and patent-pending polymer formulation.

Q-Core, Ltd.

First Time Presenter

Petach Tikva, Israel

Q-Cor Research, Development, Manufacture and INNOVATION of infusion pump platforms for today and tomorrow’s electronic drug delivery needs.

MAX Endoscopy

First Time Presenter

Macedonia, OH

MAX Endoscopy designs and manufactures innovative endoscopic accessory devices that fill unmet needs in the field of Gastrointestinal (GI) endoscopy.

Valentine Vascular, Inc.

First Time Presenter

Marco Island, FL

Valentine Vascular, Inc. (VV) is an early-stage medical device company specializing in the use of bioceramics for the treatment of post myocardial infarctions, mitral valve regurgitation, applications to coronary and peripheral stents, and other technologies in development.

Olive Medical Corp.

First Time Presenter

Sandy, UT

Developed industry's first "Single-Use" High Definition (HD) surgical camera that will provide high quality HD imaging at a fraction of the price of current market leading HD cameras.

Sphere Medical, Ltd.

Cambridge, United Kingdom

Monitoring products based on microsensor technology allowing minimally invasive, real time measurement of clinical chemistry parameters and therapeutic drug concentrations.

BioSculpture Technology, Inc.

First Time Presenter

West Palm Beach, FL

BioSculpture Technology, Inc. addresses the vast liposuction and obesity markets with fully commercially saleable, FDA-approved, proprietary medical devices and technologies protected by 15 issued US and international patents and 8 registered trademarks.

ClearView Patient Technologies

First Time Presenter

Haiku, HI

ClearView Patient Safety Technologies’ patented Flash Passive Safety™ technology reveals visible blood flow at the instant of vein penetration without activation or additional instruction. Its technology offers a universal solution that is simple and achieves reliable passive, optical venipuncture control.

Cardiox Corporation

First Time Presenter

Dublin, OH

Patented a highly accurate, minimally invasive, automatic, and continuous system to measure and monitor cardiac output, total circulating blood volume, and endogenous blood ammonia levels.

Solid-Look Corporation

First Time Presenter

New York, NY

Solid-Look Corporation is changing the surgical paradigm from 2D to 3D-HD Stereoscopic Vision for Minimally Invasive Surgery offering EndoStereoVision a superior, modular, proprietary, 3D, real time, stereoscopic vision and recording systems.

Airsonett AB

First Time Presenter

Ängelholm, Sweden

Company Description Coming Soon.

CytoSorbents, Inc.

Monmouth Junction, NJ

CytoSorb™ is a proprietary blood purification resin in clinical trials to treat severe sepsis or “overwhelming infection” by reducing cytokine storm; a major cause of organ failure and death in sepsis.